Florida Department of HealthEPI UPDATE

A weekly publication by the Bureau of Epidemiology

 

May 11, 2001

"The reason for collecting, analyzing and disseminating information on a disease is to control that disease. Collection and analysis should not be allowed to consume resources if action does not follow."

--Foege WH et al. Int. J of Epidemiology 1976; 5:29-37.

Richard S. Hopkins, MD, MSPH, Bureau Chief, State Epidemiologist

Don Ward, Surveillance Section Administrator, Epi Update Managing Editor

Jason Glisson, BS, Epi Editorial Assistant

Bureau of Epidemiology Frequent Contributors:

Steven Wiersma, MD, MPH,

Deputy State Epidemiologist

Jodi Baldy, MPH,

Biological Scientist IV

Ursula E. Bauer, PhD,

Chronic Disease Epidemiologist

Lisa Conti, DVM, MPH,

State Public Health Veterinarian

Regional Epidemiologists:

Dolly Katz, PhD, MPH,

SE Florida

Roger Sanderson, RN, MA,

SW Florida

Carina Blackmore, MS Vet. Med., PhD,

NE Florida Carina Blackmore, MS Vet. Med., PhD,

Zuber Mulla, MSPH,

Central Florida Carina Blackmore, MS Vet. Med., PhD,

Please print out this material and share with epidemiology staff, county health department directors, administrators, medical directors, nursing directors, environmental health directors and others with an interest in information of this type. Thank you.

The Bureau of Epidemiology is available 24 hours a day, 7 days a week for consultation at our main number (SunCom 205-4401 or 850/245-4401) PLEASE NOTE: Consultation after 5 p.m. & on weekends is intended for emergencies.

The Department of Health has a home on the World Wide Web at http://www.doh.state.fl.us

In this issue:

1. The Florida Department of Health Tampa Branch Laboratory is Moving

2. The FDA Commissioner’s Special Citation Team Award

3. Open Job Opportunity Announcement

4. Grand Rounds for Tuesday May 29, 2001

5. Weekly Disease Table


 

1. The Florida Department of Health Tampa Branch Laboratory is Moving

As of May 25, 2001 our new address and phone numbers are

Florida Department of Health

Bureau of Laboratories – Tampa

3602 Spectrum Blvd., Tampa, FL 33612

(813) 974-8000 or Suncom 574-8000

Fax: (813) 974-5776

conference location map

Directions from I-275

East on Fowler Ave. to Spectrum Blvd. (first traffic light after Bruce B. Downs Blvd.) Left at Spectrum Blvd. to 3602.

Directions from I-75

West on Fowler Ave. to Spectrum Blvd. Right at Spectrum Blvd. to 3602.

Tampa Branch Moving schedule word document

Please contact Dr. Lillian Stark (813/974-5990) or Dr. Deno Kazanis (813/974-8072) if there are any questions.

 

 

2. The FDA Commissioner’s Special Citation Team Award

On Friday, May 4, Roberta M. Hammond, Ph.D., accepted the FDA Commissioner’s Special Citation team award from FDA on behalf of the Outbreak Coordination Workgroup. The award was presented by Bernard A. Schwetz, D.V.M., Ph.D., Acting Principal Deputy Commissioner and Dennis E. Baker, Associate Commissioner for Regulatory Affairs in Rockville, MD. RADM Kenneth P. Moritsugu, Deputy Surgeon General, was also present. The Outbreak Coordination Workgroup is one of six workgroups that began a little over two years ago as part of the FDA-sponsored National Food Safety System (NFSS) effort to build local-state-federal partnerships in food safety. The award states: "For exceptional performance in enhancing food safety through a local-state-federal workgroup to improve coordination, cooperation and communication regarding multi-state foodborne outbreak investigations."

The Outbreak Coordination Workgroup has recently completed work on a web-based document: Multi-State Foodborne Outbreak Investigations: Guidelines for Improving Coordination and Communication. Included are outbreak information gathering guidelines, audio conference etiquette, important contacts and phone numbers, descriptions of the multi-state investigation process and more. The intent of the document is to help enhance communication and coordination during the active phases of a multi-state foodborne outbreak investigation. This document has recently been posted to FDA's Division of Federal-State Relations website at: http://www.fda.gov/ora/fed_state/NFSS/Default.htm .

Outbreak Coordination Workgroup Team members include:

Roberta M. Hammond, Ph.D.

Co-chair

Florida Department of Health

Michael P. Tormey, M.P.H.

Co-chair

Los Angeles County Department of Health Services

Frank L. Davido

Environmental Protection Agency

Jeff Farrar, D.V.M, Ph.D.

1999 co-chair

California Department of Health Services

Anthony Fiore, M.D.

Centers for Disease Control and Prevention

James J. Gibson, M.D., M.P.H.

1999 co-chair

South Carolina Department of Health

John J. Guzewich, R.S., M.P.H.

Food and Drug Administration (Center for Food Safety and Nutrition)

John Kobayashi, M.D., M.P.H.

Washington State Department of Health

Priscilla Levine

US Department of Agriculture

Ellen Morrison

Food and Drug Administration (Office of Regulatory Affairs)

Nelson P. Moyer, Ph.D.

University of Iowa Hygienic Laboratory

Louise Ogden

Minnesota Department of Agriculture

Sarah C. Pichette, M.P.H.

Food and Drug Administration (Office of Regulatory Affairs)

Jerry Rowland

Metro Health Department, Nashville, Tennessee

John P. Sanders, Jr., D.V.M.

Food and Drug Administration (Center for Food Safety and Nutrition)

Debra A. Street, Ph.D.

Food and Drug Administration (Center for Food Safety and Nutrition)

Thomas J. van Gilder, M.D., M.P.H.

Centers for Disease Control and Prevention

 

3. Open job opportunity announcement: Advanced Registered Nurse Practitioner Specialist, Bureau of STD Prevention and Control, Department of Health, Tallahassee, Florida

This is a statewide Florida ARNP Specialist career service position providing STD primary care at a county public health department clinic (20% of time) and planning, coordinating, and implementing STD program policy and protocols and performing technical assistance and quality improvement activities 80% of the time. The position is located in scenic Tallahassee, Florida, in the Bureau of STD.

EXAMPLES OF WORK PERFORMED

Provides consultation and technical assistance in evaluating the appropriateness of client care as it relates to STD services.

Serves as a resource person for technical knowledge in the field of STD services.

Provides leadership in the development and design of STD health educational materials and training of personnel.

Assists in the development of STD policies, guidelines and protocols related to the management of STD nursing care problems and the delivery of client care by nurses and clinicians.

Assesses the overall delivery of care in the STD setting and designs, implements and monitors corrective action plans.

Acts as STD clinical liaison between state and local health agencies, interpreting state policies, advising as to program changes, and clarifying clinical needs on the local level to program directors and administrators on the state level.

Participates in the development of research in the field of STD.

Monitors the delivery of STD health services by physicians, nurse practitioners, and nurses, and evaluates professional methods and techniques.

Performs complete physical appraisal of clients appropriate to background, training, and client need.

Compiles and evaluates medical histories and physical findings.

Initiates diagnostic laboratory tests and interprets and evaluates laboratory results.

Monitors medication and initiates appropriate therapies for certain conditions and alters medications according to variations in a client's response within established protocols.

Instructs advanced registered nurse practitioners in skills and abilities needed to upgrade their competencies.

Performs related work as required.

KNOWLEDGE, SKILLS AND ABILITIES

Knowledge of the principles and practices of program management and delivery of health services.

Knowledge of nursing principles, practices and techniques.

Knowledge of human anatomy and physiology.

Knowledge of STD services helpful.

Ability to plan, organize and coordinate work assignments.

Ability to apply the consultative process in problem-solving activities.

Ability to collect, interpret and analyze statistical, demographic and service data.

Ability to formulate and monitor nursing standards and operating policies and procedures.

Ability to develop and implement various program monitoring methodologies and techniques.

Ability to communicate effectively.

Ability to establish and maintain effective working relationships with others.

Ability to perform compete physical appraisals of clients.

Ability to manage the care of clients.

Ability to initiate diagnostic laboratory tests and evaluate the results.

Ability to administer prescribed medications.

Ability to compile and evaluate medical histories and other clinical and laboratory data.

MINIMUM QUALIFICATIONS

Certification as an Advanced Registered Nurse Practitioner (ARNP) in accordance with Florida Statute 464, a bachelor's degree from an accredited college or university with a major in nursing and four years of professional nursing experience, two years of which must have been in a ARNP capacity.

A master's degree from an accredited college or university in nursing can substitute for two years of the required general professional nursing experience.

NOTE

Preference will be given to applicants with experience working in STD clinics.

A State of Florida job application will need to be completed and mailed or FAXED.

http://www.myflorida.com/dms/hrm/jobsdirect/app.pdf is the state of FL job application form.

Pay grade 78; Annual Salary Range: $38,459.72 to $71,547.32

Contact:

TAMMY ARNOLD
BUREAU OF STD
DEPT OF HEALTH
4052 BALD CYPRESS WAY BIN A19
TALLAHASSEE, FL. 32399-1716
Phone:
(850) 245-4303 Suncom: 205-4303 FAX: (850) 414-8103

 

 

4. Grand Rounds for Tuesday May 29, 2001

"Surveillance for West Nile (WN) Virus"

Lisa Conti, DVM, MPH State Public Health Veterinarian, Bureau of Epidemiology, Florida Department of Health, and Robin Oliveri Arbovirus Surveillance Coordinator, Bureau of Epidemiology

11:00 AM – 12:00 PM EST

Dial-in by 11:10 AM at (850) 487-8587 or SunCom 277-8587

Abstract

Florida is conducting WN virus surveillance in addition to St. Louis encephalitis and eastern equine encephalitis monitoring activities. During its brief history, WN has manifested itself in the United States with bird die-offs, especially American crows. Thus, tracking bird mortality in Florida is considered a useful tool for WNV detection and surveillance. WN has also caused morbidity and mortality among people and other animals, and has been identified in a number of vector species. No human or animal cases have been reported in Florida. The state's interagency effort includes looking for evidence of WN virus in wild birds, sentinel chickens, horses and people and a protocol for mosquito surveillance when WN virus is detected in Florida.

Additional Information

Further details regarding the audio-conference call and PowerPoint files will be posted on the Bureau of Epidemiology Intranet web site. Be sure and register online for nursing CEU's and contact hours for environmental health professionals. We will also be providing CEU's for Veterinary Medicine. Information about up-coming topics and presenters will also be posted in the Epi Update. If either of these access points is unavailable to you, please e-mail Melanie Black [Melanie_Black@doh.state.fl] or telephone (850) 245-4444 ext. 2448 (SunCom 205-4444 ext. 2448) to request presentation materials.

Important

While we realize you might not always be able to call in at 11:00 AM, it can be distracting to the speaker and others in the audience when participants dial-in throughout the hour. Please try to call in on time and remember to put your phones on mute so as not to disturb others. Thank you for your cooperation.

 

 

5. Weekly Disease Table (Week 18)

DISEASE

1999 TO
WEEK 18

2000 TO
WEEK 18

3-YEAR
AVERAGE
TO WEEK 18*

2000
TOTAL
CASES

2001 TO
WEEK 18

2001
WEEK 18
ONLY

Animal Rabies

59

45

60.3

161

85

10

Anthrax

0

0

0

0

0

0

Botulism, foodborne

0

0

0

0

0

0

Botulism, infant

0

0

0

0

0

0

Botulism, wound

0

0

0

0

0

0

Botulism, other

0

0

0

0

0

0

Brucellosis

0

1

0.7

2

1

0

Campylobacteriosis

242

248

230.7

1026

217

15

Ciguatera

1

0

0.3

14

0

0

Cryptosporidiosis

28

14

23.3

180

22

1

Cyclosporiasis

0

1

1

9

22

0

Dengue Fever

1

0

0.7

3

2

0

Diphtheria

0

0

0

0

0

0

Ehrlichiosis, human

0

0

0

0

0

0

Encephalitis, chickenpox

0

0

0

0

0

0

Encephalitis, Eastern Equine

0

0

0

0

0

0

Encephalitis, herpes

2

2

2.3

7

0

0

Encephalitis, influenza

0

1

0.3

1

0

0

Encephalitis, measles

0

0

0

0

0

0

Encephalitis, mumps

0

0

0

0

0

0

Encephalitis, other

2

1

1.3

8

1

0

Encephalitis, St. Louis

0

0

0

0

0

0

Encephalitis, Venezuelan

0

0

0

0

0

0

Encephalitis, Western Equine

0

0

0

0

0

0

Escherichia Coli 0157:H7

11

12

9

95

6

0

Escherichia Coli, other

7

3

4

13

2

0

Giardiasis

259

288

292.3

1466

248

24

H. Influenzae Cellulitis

0

0

0.7

1

0

0

H. Influenzae Epiglottitis

0

0

0

1

0

0

H. Influenzae Meningitis

7

1

4.3

11

3

0

H. Influenzae Pneumonia

2

2

2.3

7

11

0

H. Influenzae Prim.Bacteremia

7

14

9

57

33

3

H. Influenzae Septic Arthritis

0

0

0

1

0

0

Hantaviris Infection

0

0

0

0

0

0

Hemolytic Uremic Syndrome

1

4

1.7

17

1

0

Hemorrhagic Fever

0

0

0

0

0

0

Hepatitis A

203

164

184.7

589

172

11

Hepatitis B

110

109

108

526

118

11

Hepatitis B (+HbsAg in pregnant women)

5

99

34.7

492

84

10

Hepatitis, Perinatal Hep B

0

0

0

1

2

0

Hepatitis C

13

5

6

19

4

0

Hepatitis, Non-A, Non-B

0

3

8.3

6

1

0

Hepatitis, Other, including unspecified

6

4

3.7

7

3

0

Lead Poisoning

495

368

453

1219

184

11

Legionellosis

7

13

11.3

51

11

2

Leprosy

0

0

1

4

0

0

Leptospirosis

0

0

0

2

0

0

Listeriosis

5

9

4.7

32

7

0

Lyme Disease

3

6

6

54

2

1

Malaria

25

19

20.7

90

15

1

Measles

1

0

0.7

2

0

0

Meningitis, Group B Strep

5

5

5.3

21

4

0

Meningitis, List Monocytogenes

2

1

2

7

0

0

Meningitis, Meningococcal

17

12

14.3

41

30

1

Meningitis, other

17

30

21.3

110

20

1

Meningitis, Strep Pneumoniae

49

45

45.7

112

24

0

Meningococcemia, disseminated

25

28

28.3

80

24

5

Mercury Poisoning

1

3

1.3

11

1

1

Mumps

1

1

3.3

4

0

0

Neurotoxic Shellfish Poisoning

0

0

0

0

0

0

Pertussis

9

13

11

48

5

0

Plague, Bubonic

0

0

0

0

0

0

Plague, Pneumonic

0

0

0

0

0

0

Poliomyelitis

0

0

0

0

0

0

Psittacosis

0

0

0

3

0

0

Q Fever

0

0

0

0

0

0

Human Rabies

0

0

0

0

0

0

Rocky Mountain Spotted Fever

1

0

0.7

1

1

0

Rubella

0

1

0.7

2

1

1

Rubella, Congenital

0

0

0

1

0

0

Salmonellosis

502

448

464.7

2756

486

33

Shigellosis

434

386

419.3

1292

193

14

Smallpox

0

0

0

0

0

0

Staphylococcus Aureus (GISA/VISA)

0

0

0

0

0

0

Staphylococcus Aureus (GRSA/VRSA)

0

0

0

0

0

0

Streptococcal Disease, Invasive Group A

17

51

30.3

147

60

2

Streptococcus Pneumoniae, Invasive

198

370

252.7

1150

399

17

Tetanus

1

0

0.7

1

2

0

Toxoplasmosis

4

2

3.3

12

4

1

Trichinosis

0

0

0

1

0

0

Tularemia

0

0

0

0

0

0

Typhoid Fever

19

1

9

12

3

1

Vibrio Alginolyticus

3

2

2

15

1

1

Vibrio Cholerae Type 01

0

0

0

0

0

0

Vibrio Cholerae Non-01

3

3

2.3

4

0

0

Vibrio Fluvialis

1

0

0.3

2

0

0

Vibrio Hollisae

3

3

2.7

3

0

0

Vibrio Mimicus

1

1

0.7

2

0

0

Vibrio, other

1

0

0.3

2

0

0

Vibrio Parahaemolyticus

2

1

1.7

16

0

0

Vibrio Vulnificus

2

0

1.3

13

2

2

Yellow Fever

0

0

0

0

0

0


* The column of data representing the "3-year average to week ##" is the average of years 1998, 1999 and 2000 cases to the current listed week (##).